Canada Molecular Cytogenetics Market Size & Outlook

The molecular cytogenetics market in Canada is expected to reach a projected revenue of US$ 332.0 million by 2028. A compound annual growth rate of 13.2% is expected of Canada molecular cytogenetics market from 2021 to 2028.
Revenue, 2020 (US$M)
$123.4
Forecast, 2028 (US$M)
$332.0
CAGR, 2021 - 2028
13.2%
Report Coverage
Canada

Canada molecular cytogenetics market highlights

  • The Canada molecular cytogenetics market generated a revenue of USD 123.4 million in 2020 and is expected to reach USD 332.0 million by 2028.
  • The Canada market is expected to grow at a CAGR of 13.2% from 2021 to 2028.
  • In terms of segment, oncology was the largest revenue generating application in 2020.
  • Personalized Medicine is the most lucrative application segment registering the fastest growth during the forecast period.


Molecular cytogenetics market data book summary

Market revenue in 2020USD 123.4 million
Market revenue in 2028USD 332.0 million
Growth rate13.2% (CAGR from 2020 to 2028)
Largest segmentOncology
Fastest growing segmentPersonalized Medicine
Historical data2018 - 2019
Base year2020
Forecast period2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentationGenetic Disorders, Oncology, Personalized Medicine, Other Applications
Key market players worldwideDanaher Corp, Abbott Laboratories, Bio-Rad Laboratories Inc, Illumina Inc, Sysmex Corp, Roche Holding AG, BioView, MetaSystems, Agilent Technologies Inc, Revvity Inc


Other key industry trends

  • In terms of revenue, Canada accounted for 7.5% of the global molecular cytogenetics market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In North America, U.S. molecular cytogenetics market is projected to lead the regional market in terms of revenue in 2028.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 332.0 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Molecular Cytogenetics Market Companies

Name Profile # Employees HQ Website

Canada molecular cytogenetics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular cytogenetics market will help companies and investors design strategic landscapes.


Oncology was the largest segment with a revenue share of 40.03% in 2020. Horizon Databook has segmented the Canada molecular cytogenetics market based on genetic disorders, oncology, personalized medicine, other applications covering the revenue growth of each sub-segment from 2018 to 2028.


The market is rapidly transitioning from older technologies to newer and more sophisticated technologies that offer better insights at nucleotide level. Some of the factors boosting market growth are the presence of advanced biotech companies in the U.S. that comply with Canadian regulations and operate almost in same way as in the U.S.

The Canadian government in collaboration with research institutes offer advanced short- and long-term training programs, such as BCIT’s clinical genetics technology program. Such programs help train students, technicians, cytogeneticists, clinicians, and scientists on how to investigate and handle various genetic diagnostic tests for diseases like cancers, Down syndrome, and others.

The Canadian College of Medical Geneticists is an organization that establishes and maintains quality, safety, and ethical standards for cytogenetics services in Canada. Professionals and laboratories offering genetic diagnosis services are required to be accredited by the Canadian Medical Association to ensure safe and ethical handling and practice during genetic testing.

Reasons to subscribe to Canada molecular cytogenetics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Canada molecular cytogenetics market databook

  • Our clientele includes a mix of molecular cytogenetics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Canada molecular cytogenetics market , including forecasts for subscribers. This country databook contains high-level insights into Canada molecular cytogenetics market from 2018 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Canada molecular cytogenetics market size, by application, 2018-2028 (US$M)

Canada Molecular Cytogenetics Market Outlook Share, 2020 & 2028 (US$M)

Canada molecular cytogenetics market size, by application, 2018-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more